previous
identifi
truncat
antigen
fragment
name
protein
c
amino
acid
aa
immunodomin
fragment
spike
protein
sever
acut
respiratori
syndrom
sar
coronaviru
sarscov
success
express
protein
c
use
baculoviru
system
frugiperda
cell
recombin
baculoviru
express
protein
c
first
character
use
five
sar
convalesc
human
sera
five
normal
human
sera
result
show
protein
c
authent
antigen
sarscov
antibodi
spike
proteinbas
immunoflouresc
assay
ifa
base
recombin
system
assess
panel
clinic
sampl
collect
sar
epidem
singapor
includ
sampl
clinic
confirm
sar
nonsar
patient
sera
normal
sera
result
compar
commerci
sar
ifa
kit
euroimmun
germani
convent
ifa
test
perform
singapor
gener
hospit
sarsposit
serum
sampl
could
recogn
ifa
give
specif
sensit
compat
whole
virusbas
ifa
assay
crossreact
serum
sampl
infecti
bronchiti
viru
ibv
transmiss
gastroenter
viru
tgev
detect
assay
thu
spike
proteinbas
ifa
could
offer
safer
procedur
perform
laboratori
could
mimic
whole
viru
basedifa
without
loss
sensit
specif
also
userfriendli
costeffect
whole
virusbas
ifa
sever
acut
respiratori
syndrom
sar
atyp
pneumonia
unknown
aetiolog
first
identifi
guangdong
provinc
china
see
front
matter
elsevi
bv
right
reserv
ber
may
diseas
outbreak
spread
worldwid
affect
thousand
individu
result
death
caus
agent
sarsassoci
coronaviru
sarscov
novel
cov
order
nidoviral
famili
coronavirida
genu
coronaviru
recogn
end
februari
declar
global
threat
health
diseas
highli
contagi
sarscov
maintain
pathogen
transmiss
could
becom
first
sever
new
diseas
centuri
global
epidem
potenti
phylogenet
analys
indic
sar
coronaviru
close
relat
previous
character
coronavirus
form
distinct
group
within
genu
ruan
et
al
coronavirida
famili
contain
envelop
positivestrand
rna
virus
caus
respiratori
enter
diseas
human
anim
genom
around
kb
largest
found
rna
virus
encod
put
protein
includ
major
structur
protein
spike
nucleocapsid
n
membran
small
envelop
e
spike
protein
larg
membran
glycoprotein
form
peplom
bind
receptor
covsuscept
cell
induc
cell
fusion
protein
also
wellknown
neutral
antigen
mani
coronaviru
homberg
jackwood
hilt
callebaut
et
al
gomez
et
al
sar
spike
protein
low
level
similar
pairwis
amino
acid
aa
ident
compar
spike
protein
cov
lu
et
al
variou
diagnost
method
sarscov
detect
avail
sequenc
detect
serolog
assay
etc
sequenc
detect
sarscov
infect
use
realtim
rtpcr
use
detect
viral
rna
clinic
sampl
although
sensit
specif
serolog
assay
drawback
use
realtim
rtpcr
equip
expens
differ
optim
rna
extract
delay
process
specimen
deterior
sampl
may
lower
effici
assay
drawback
make
realtim
rtpcr
difficult
procedur
use
major
clinic
laboratori
especi
develop
countri
current
commonli
use
diagnost
assay
detect
sarscov
detect
antibodi
immunoflouresc
assay
ifa
ifa
recogn
bgold
standardq
tang
et
al
use
inactiv
sarscovinfect
cell
fix
slide
antigen
detect
sar
antibodi
serum
sampl
known
convent
whole
viru
ifa
detect
posit
sarscov
infect
use
sera
collect
earli
day
howev
convent
whole
viru
ifa
conveni
sinc
initi
util
infecti
sarscov
infect
cell
cultur
fixat
slide
although
inactiv
ifa
slide
handl
biosafeti
level
laboratori
initi
infect
procedur
need
carri
research
facil
make
whole
viru
ifa
difficult
perform
laboratori
risk
contamin
deal
live
viru
due
current
problem
safeti
issu
whole
viru
ifa
safer
serolog
assay
littl
risk
contamin
need
diagnosi
sarscov
infect
led
develop
nucleocapsid
proteinbas
elisa
immunoblot
assay
howev
recent
littl
inform
avail
evalu
spike
proteinbas
immunoassay
detect
specif
antibodi
sar
patient
three
serotyp
coronavirus
class
contain
mammalian
virus
class
contain
avian
virus
enjuan
et
al
analysi
sarscov
genom
show
viru
belong
three
class
describ
although
genom
organ
coronavirus
interpret
suggest
sarscov
protein
share
low
homolog
known
coronavirus
rota
et
al
sarscov
spike
gene
encod
glycoprotein
approxim
kda
contain
amino
acid
normal
cleav
domain
domain
jackwood
et
al
recent
angiotensin
convert
enzym
recogn
site
identifi
spike
protein
domain
function
receptor
sarscov
human
li
et
al
spike
protein
may
mediat
membran
fusion
induc
neutral
antibodi
host
rais
possibl
antibodi
sarscov
spike
protein
may
good
marker
earli
detect
neutral
sarscov
infect
previou
studi
identifi
major
immunodomin
domain
sarscov
spike
protein
aa
aa
name
protein
c
repres
segment
domain
lu
et
al
studi
diagnost
potenti
spike
proteinbas
immunoassay
base
protein
c
express
recombin
baculoviru
cell
panel
sera
contain
sarsposit
sampl
collect
day
onset
sar
symptom
nonsar
serum
sampl
normal
serum
sampl
subject
spike
proteinbas
ifa
test
specif
sensit
test
compar
commerci
avail
ifa
euroimmun
germani
convent
ifa
perform
singapor
gener
hospit
sgh
sarscov
use
experi
isol
provid
sgh
genbank
access
frugiperda
cell
maintain
propag
ii
serumfre
gibco
medium
vero
cell
propag
dmem
medium
supplement
fb
viral
titrat
infect
perform
describ
previous
human
sera
use
studi
collect
sgh
singapor
tan
tock
seng
hospit
singapor
includ
studi
serum
sampl
avail
clinic
record
twentyon
sera
confirm
sar
patient
sera
autoimmun
diseas
patient
sera
dengu
fever
patient
sera
patient
commun
acquir
pneumonia
sera
patient
renal
failur
sera
healthi
donor
sera
kept
ice
collect
heatinactiv
h
test
four
infecti
bronchiti
viru
ibv
infect
chicken
sera
seven
transmiss
gastroenter
viru
tgev
infect
swine
sera
obtain
temasek
life
scienc
laboratori
use
check
crossreact
total
cell
lysat
cell
infect
recombin
baculoviru
express
protein
c
immunoblot
nitrocellulos
membran
biorad
sera
includ
five
sar
convalesc
human
sera
five
normal
human
sera
screen
dilut
follow
peroxidaseconjug
secondari
antibodi
dako
denmark
accord
manufactur
instruct
dab
tetrahydrochlorid
pierc
il
usa
use
horseradish
peroxidas
hrp
substrat
develop
reaction
membran
neg
control
includ
test
cell
grown
micropl
nunc
nunclon
delta
surfac
cat
infect
recombin
baculoviru
express
protein
c
moi
cell
incub
recombin
baculoviru
h
chang
inoculum
incub
anoth
h
infect
cell
fix
plate
ethanol
min
room
temperatur
cell
well
react
human
serum
sampl
dilut
phosphatebuff
salin
pb
h
moist
chamber
follow
cell
wash
pbst
twice
interv
fitcconjug
rabbit
antihuman
immunoglobulin
g
igg
dako
cat
dilut
use
fluoresc
studi
optim
serum
dilut
previous
determin
igtot
detect
data
shown
posit
control
antibodyspecif
protein
c
dilut
fitcconjug
rabbit
antiguinea
pig
immunoglobulin
dako
cat
use
test
crossreact
cell
incub
tgev
ibv
serum
sampl
dilut
fitcconjug
rabbit
antiswin
immunoglobulin
dako
cat
fitcconjug
rabbit
antichicken
immunoglobulin
dako
cat
respect
stain
pattern
cell
examin
invert
fluoresc
microscop
olympu
use
object
eye
piec
appropri
barrier
excit
filter
optim
fitc
visual
signal
captur
digit
camera
imag
system
nikon
optim
condit
defin
reaction
maximum
fluoresc
signal
observ
background
confoc
microscopi
cell
cultur
fourwel
chamber
slide
iwaki
infect
fixat
ifa
perform
describ
follow
ifa
slide
observ
invert
confoc
invert
laser
microscop
zeiss
use
argon
laser
fitc
filter
perform
laboratori
sgh
describ
previous
et
al
cytopathogen
effect
seen
cell
monolay
follow
cell
harvest
spot
onto
teflonprint
microscop
slide
precis
lab
product
llc
cat
fix
cold
aceton
uninfect
vero
cell
use
control
experi
human
serum
sampl
test
dilut
fitclabel
antihuman
igtot
dilut
commerci
sar
ifa
kit
purchas
medizinisch
labordiagnostika
germani
test
conduct
accord
manufactur
instruct
recommend
serum
sampl
dilut
use
primari
antibodi
fitclabel
secondari
antibodi
result
interpret
accord
instruct
provid
confirm
authent
protein
c
express
baculoviru
system
specif
antigen
sarscov
infect
immunoblot
ifa
carri
use
five
sar
convalesc
human
sera
five
normal
human
sera
fig
immunoblot
show
band
indic
protein
c
express
baculoviru
system
antigen
antibodi
detect
sarscov
infect
repres
fig
ifa
test
use
confoc
microscopi
five
sar
convalesc
human
sera
show
fluoresc
ring
around
cell
normal
human
sera
show
specif
stain
repres
fig
fig
also
indic
fluoresc
confin
cytoplasm
find
show
protein
c
maintain
antigen
sarscov
whole
spike
protein
thu
spike
proteinbas
ifa
potenti
replac
whole
viru
ifa
detect
sarscov
infect
investig
specif
protein
c
react
ibvinfect
chicken
serum
sampl
tgevinfect
swine
serum
sampl
spike
proteinbas
ifa
neg
result
observ
indic
crossreact
protein
c
anim
coronavirus
tabl
also
conduct
pairwis
nucleotid
ident
analysi
protein
c
spike
protein
human
coronaviru
analysi
reveal
low
level
similar
protein
c
human
coronaviru
well
anim
coronavirus
tabl
indic
protein
c
uniqu
sarscov
unlik
caus
cross
reaction
result
spike
proteinbas
ifa
found
compar
convent
ifa
term
sensit
specif
tabl
ifa
could
identifi
posit
sera
give
sensit
fals
posit
result
serum
sampl
collect
nonsar
patient
sera
serum
sampl
collect
normal
donor
indic
specif
also
test
specif
abovement
sera
react
noninfect
cell
posit
reaction
obtain
indic
spike
proteinbas
ifa
specif
fig
show
repres
ifa
result
detect
posit
serum
sampl
use
spike
proteinbas
ifa
compar
convent
ifa
perform
sgh
commerci
sar
ifa
kit
euroimmun
convent
ifa
commerci
ifa
euroimmun
use
sarspo
itiv
serum
sampl
fluoresc
signal
also
observ
cytoplasm
vero
cell
spike
protein
sarscov
made
two
subunit
fragment
near
nterminu
fragment
near
cterminu
subunit
form
globular
head
stalk
spike
protein
bosch
et
al
play
import
role
specif
receptor
recognit
cell
fusion
spike
protein
contain
import
viru
neutral
epitop
amino
acid
chang
spike
protein
known
profound
effect
virul
tropism
known
coronaviru
leparcgoffart
et
al
sanchez
et
al
also
low
level
similar
pairwis
amino
acid
ident
predict
amino
acid
sequenc
protein
sarscov
coronavirus
lu
et
al
pairwis
analysi
c
domain
spike
protein
human
coronavirus
show
even
lower
similar
compar
exist
human
coronavirus
tabl
moreov
found
serolog
reactiv
sarscov
among
patient
respiratori
diseas
hong
kong
peiri
et
al
suggest
crossreact
antibodi
previous
known
coronavirus
antibodi
sarscov
huang
et
al
recent
li
et
al
report
angiotensin
convert
enzym
recogn
site
spike
protein
domain
function
receptor
sarscov
compar
sequenc
protein
c
aa
spike
protein
recogn
site
found
recognit
domain
overlap
protein
c
sequenc
found
domain
sarscov
spike
protein
high
affin
recognit
domain
import
grant
sarscov
abil
bind
mediat
viru
entri
cell
caus
infect
henc
induc
earli
immun
respons
protein
c
overlap
recognit
site
believ
antibodi
protein
c
may
good
candid
develop
effect
sensit
detect
assay
sarscov
studi
first
show
immunogen
protein
cbase
ifa
sensit
specif
method
detect
sarscov
infect
ifa
consid
bgold
standardq
detect
sarscov
infect
techniqu
simpl
inexpens
perform
accept
sensit
specif
detect
sarscov
infect
ifa
also
known
abil
detect
antibodi
respons
earli
day
therefor
develop
ifa
techniqu
use
recombin
baculoviru
express
c
domain
spike
protein
cell
spike
proteinbas
ifa
use
antigen
protein
c
sensit
specif
compar
convent
commerci
ifa
tabl
observ
bringq
fluoresc
pattern
spike
proteinbas
ifa
well
convent
commerci
sar
ifa
analyz
posit
human
sera
local
studi
use
invert
confoc
microscop
show
protein
c
local
cytoplasm
cell
thu
form
bringq
fluoresc
pattern
fig
howev
term
sensit
detect
sarscov
antibodi
serum
sampl
spike
proteinbas
ifa
util
onetenth
serum
use
commerci
ifa
conduct
experi
optim
condit
use
ifa
identifi
best
dilut
serum
data
shown
found
spike
proteinbas
ifa
detect
sarscov
specif
antibodi
lower
dilut
compar
dilut
commerci
convent
ifa
might
due
overexpress
protein
c
system
thu
spike
proteinbas
ifa
sensit
compar
exist
ifa
moreov
protein
c
abl
mimic
antigen
whole
sarscov
although
develop
basi
truncat
immunogen
fragment
aa
spike
protein
futur
develop
assay
protein
c
spike
protein
possibl
manipul
live
sarscov
biohazard
work
need
laboratori
recent
sar
outbreak
due
laboratori
escap
live
viru
occur
singapor
taiwan
china
safeti
therefor
becom
paramount
issu
initi
work
whole
viru
ifa
requir
high
stringenc
facil
deal
infecti
viru
diagnost
techniqu
need
elimin
possibl
contamin
escap
pathogen
viru
spike
proteinbas
ifa
compar
detect
rate
two
avail
exist
ifa
could
conduct
biosafeti
level
laboratori
safer
diagnost
procedur
exist
ifa
summari
spike
proteinbas
ifa
costeffect
method
detect
antibodi
sarscov
littl
risk
infect
reliabl
sensit
accur
whole
virusbas
ifa
easi
start
userfriendli
util
easili
major
laboratori
without
fear
infect
believ
spike
proteinbas
ifa
appropri
method
daili
routin
diagnosi
sarscov
infect
